DHEA (Intrarosa) vs. Vaginal Estrogen for Painful Sex

If sex has started to hurt, or if you've quietly stopped wanting it because you brace for the burning and tearing feeling that follows, please hear this first: you are not broken, and you are far from alone. What you're describing has a name, a clear biological cause, and several genuinely effective treatments. Many women in their late forties and fifties find that intercourse goes from comfortable to painful over a year or two, and they assume it's something they just have to live with. It is not. When the conversation turns to fixing it, two prescription options come up again and again, and they are easy to confuse: a daily vaginal insert called Intrarosa (the generic name is prasterone, a form of DHEA), and the long-trusted family of low-dose vaginal estrogen products. They sound similar, they're both used inside the vagina, and they treat the same problem. But they work in slightly different ways, and the right pick depends on you.

This guide walks through how each one actually works, what the research shows about whether they help, how they compare on safety, cost, and convenience, and how to figure out which conversation to have with your provider. The goal is to leave you feeling informed and hopeful, not overwhelmed.

Why sex starts to hurt in the first place

The pain you're feeling almost always traces back to one thing: falling estrogen. The tissues of the vulva, vagina, and lower urinary tract are richly supplied with estrogen receptors, and estrogen is what keeps them thick, elastic, well lubricated, and resilient. As you move through perimenopause and into menopause, estrogen drops, and those tissues respond by thinning, losing stretch, producing less natural lubrication, and becoming more fragile. The medical name for this cluster of changes is the genitourinary syndrome of menopause, or GSM, and it covers vaginal dryness, burning, itching, painful sex (the clinical term is dyspareunia), and even recurring urinary tract infections and urgency.

Here is the part that matters most, and that The Menopause Society emphasizes repeatedly: unlike hot flashes, which usually fade with time, GSM tends to get worse the longer it goes untreated. Estrogen does not come back on its own. So waiting it out, which works for so many other menopause symptoms, is exactly the wrong strategy here. The good news is that local treatments restore the tissue rather than just masking the symptom, and most women feel meaningfully better within a few weeks to a few months. If you'd like a fuller overview of the territory first, our guide to vaginal dryness and painful sex in menopause walks through the whole picture, and our broader page on menopause symptoms can help you see how this connects to everything else you may be feeling.

How vaginal estrogen works

Low-dose vaginal estrogen does the most direct thing imaginable: it puts a small amount of estrogen right where the tissue is starved for it. The estrogen binds to those local receptors, the tissue plumps back up, blood flow improves, natural lubrication returns, and the vaginal pH shifts back toward its healthier, more acidic premenopausal range. It is, in a sense, replacing exactly what the tissue is missing.

It comes in several forms, and the variety is genuinely useful because women's preferences differ so much. There are creams (such as estradiol or conjugated estrogen cream), small vaginal tablets and inserts (Vagifem and its generics, and Imvexxy), and a soft, flexible ring (Estring) that sits in place and releases estrogen steadily for about three months before you swap it. Regimens differ by product, and this is where a lot of confusion starts. Tablets and inserts typically run nightly for about two weeks and then drop to twice a week. Estradiol cream is dosed differently: the Estrace label starts at 2 to 4 grams daily for one to two weeks, reduces to half that for a similar period, then settles at about 1 gram one to three times a week. Premarin Vaginal Cream has no loading phase at all and runs on a cycle instead, 21 days on and 7 days off, usually starting at 0.5 grams. The ring is the lowest-effort option for many women because there's nothing to remember most days.

A crucial point about safety: the dose is tiny and stays mostly local. The Mayo Clinic and Cleveland Clinic both note that low-dose vaginal estrogen results in very little estrogen reaching the bloodstream, which is a big part of why it's considered appropriate even for many women who can't or don't want to take systemic hormones. In February 2026 the FDA approved label changes that removed the long-standing boxed warning from a first group of menopausal hormone products, including the Estring vaginal ring, acknowledging that the warnings women had been reading for two decades came from studies of oral, whole-body hormone therapy and never really fit these local products. One practical caveat: that rollout is happening product by product rather than all at once, so check the label of the specific product you are prescribed. Premarin Vaginal Cream and Imvexxy still carried a boxed warning as this was written. You can read more about what that shift means in our coverage of the FDA removing the HRT black box warning.

How Intrarosa (DHEA / prasterone) works

Intrarosa takes a cleverly different route. Instead of delivering estrogen, it delivers a building block called DHEA (dehydroepiandrosterone), which the FDA approved in this vaginal insert form back in 2016 specifically for moderate to severe painful sex due to menopause. You insert one 6.5 mg insert at bedtime, every night.

The interesting science is what happens next. Your vaginal cells contain the enzymes needed to convert that DHEA, right there inside the tissue, into both estrogens and androgens (testosterone-family hormones). Researchers call this local conversion process intracrinology, which is a fancy way of saying the hormone is made and used inside the very cells that need it, and then broken down before much of it can travel anywhere else. So the tissue gets the estrogen benefit, plus an androgen benefit that plain estrogen doesn't provide. Because the vulvar vestibule (the tender entrance area where a lot of penetration pain actually originates) is especially rich in androgen receptors, some women and clinicians find the androgen angle appealing for that specific kind of pain. Studies have shown prasterone improves the cell makeup of the vaginal lining, restores a healthier pH, and reduces pain during sex, all while keeping blood hormone levels within the normal postmenopausal range.

Intrarosa vs. vaginal estrogen: what the research actually shows

Here's the headline that should take pressure off your decision: when researchers compare these two approaches head to head and across pooled trials, they find little meaningful difference in how well they relieve painful sex. A network meta-analysis drawing on data from thousands of women across dozens of trials concluded that DHEA and vaginal estrogen perform similarly for dyspareunia, and twelve-week studies of prasterone show its effectiveness sits right alongside that of vaginal estradiol and conjugated estrogen.

This is reflected in major guidance. In its 2025 guideline on GSM, developed with the urology and urogynecology societies, the American Urological Association recommends that clinicians offer either low-dose vaginal estrogen or vaginal DHEA to improve dryness and painful sex. The Menopause Society likewise lists low-dose vaginal estrogen, intravaginal DHEA, and the oral medication ospemifene together as legitimate, evidence-backed prescription options for GSM. In other words, the experts treat these as two good roads to the same destination rather than a clear winner and a runner-up.

So if effectiveness is largely a tie, the decision usually comes down to the practical and personal factors below.

Convenience and dosing

Intrarosa is a once-nightly insert, every night, with no step-down. Some women like the simplicity of a single consistent routine; others find nightly application tedious over the long run. Vaginal estrogen is more flexible, though the schedule depends on which one you get: tablets and inserts settle into a twice-weekly rhythm after a two week start, estradiol cream tapers to roughly 1 gram one to three times weekly, Premarin cream runs a 21 days on and 7 days off cycle, and the Estring ring asks almost nothing of you for three months at a stretch. If "set it and forget it" matters to you, the ring is hard to beat. If you don't mind a nightly habit, Intrarosa is straightforward.

The androgen factor

Because Intrarosa produces local androgens as well as estrogen, it's sometimes considered when entrance pain and tissue sensitivity are prominent, or when a woman is curious about the testosterone-pathway benefits. This is also why some women interested in the broader role of androgens in menopause ask about it. If that topic intrigues you, our guide to testosterone for women goes deeper.

Cost and insurance

This is often the real deciding factor. Several vaginal estrogen products, including generic estradiol cream and generic vaginal tablets, are available at relatively low cost, while Intrarosa is brand-name only, which can make it pricier depending on your coverage. Prices and coverage shift constantly, so it's worth checking both before you commit. Our overviews of HRT costs in 2026 and using GoodRx to lower HRT costs can help you compare real numbers, and an HSA or FSA may cover either option.

Safety, and the question so many women are really asking

If you've had breast cancer, or you carry a strong family history, your first question is almost certainly about safety, and it deserves a careful answer. Both low-dose vaginal estrogen and vaginal DHEA are designed to act locally and to keep circulating hormone levels in the normal postmenopausal range, which is precisely why they're viewed so differently from whole-body hormone therapy. Intrarosa's label places no restriction on how long you can use it, and the FDA's 2026 labeling changes removed the boxed warning from several products in this category, though not yet from all of them. Two things belong in this conversation that rarely survive into the marketing. Estrogen is a metabolite of prasterone, and Intrarosa's own label states that it has not been studied in women with a history of breast cancer. Ospemifene, listed above as a third option, carries its own boxed warning for endometrial cancer and cardiovascular disorders. None of that makes these products wrong for you. It makes them a conversation to have with your oncology team rather than a decision to reach from a website.

That said, this is exactly the situation where a knowledgeable provider matters most, because the nuances of your personal history, especially with hormone-sensitive cancers or certain clotting risks, can tip the decision one way or another. The American College of Obstetricians and Gynecologists (ACOG) and The Menopause Society both support shared, individualized decision-making here rather than blanket rules. If breast cancer is part of your story, please start with our dedicated guide to managing menopause after breast cancer and bring it to your oncology team. And whatever your history, never assume a symptom is "just dryness" without a check-in; new bleeding or unusual discharge always warrants a call, as we explain in what bleeding on HRT means.

What about non-prescription options?

Plenty of women want to start gentler, and that's reasonable. Over-the-counter vaginal moisturizers (used regularly, not just before sex) and lubricants (used during sex) can take the edge off mild dryness and are a sensible first step. But it's worth being honest about the limits: moisturizers soothe the surface, while prescription estrogen and DHEA actually rebuild the tissue from within. For mild symptoms, the non-prescription route may be enough. For the moderate to severe pain that makes you dread intimacy, the evidence points clearly toward the hormonal options. There's no prize for white-knuckling it.

How to choose, and what to do next

A reasonable way to think about it: if you want the lowest-effort routine, lean toward the vaginal estrogen ring. If cost is your biggest concern, generic vaginal estrogen cream or tablets are usually the most affordable. If you're drawn to the added androgen pathway or you've discussed entrance-specific pain with your provider, Intrarosa is a strong candidate. And if one option doesn't agree with you (some women find a particular cream irritating, or simply dislike a nightly insert), the other is a fully legitimate plan B. You are not locked in.

Before your appointment, jot down when the pain started, where exactly it hurts, what you've already tried, and your full medical history. Walking in prepared changes the whole conversation. Our appointment prep tool and our list of questions to ask your HRT doctor can help you make the most of your visit, and if you're not sure your current clinician is comfortable with this, our directory of HRT-knowledgeable providers (including telehealth options) can connect you with someone who treats this every day. You deserve to enjoy intimacy again, and for most women, that's an entirely realistic goal.

"Painful sex after menopause is common, it is biological, and it is treatable. Whether you choose vaginal estrogen or Intrarosa, the goal is the same: comfortable, restored tissue and a body that feels like yours again."

Medical Disclaimer: This article is for general educational purposes only and is not medical advice. Hormone therapy and menopause treatment decisions are individual and should be made with a qualified healthcare provider who knows your full history. Always consult your provider before starting or changing any treatment.